157 related articles for article (PubMed ID: 11589011)
1. The substrate range of tripeptidyl-peptidase I.
Bernardini F; Warburton MJ
Eur J Paediatr Neurol; 2001; 5 Suppl A():69-72. PubMed ID: 11589011
[TBL] [Abstract][Full Text] [Related]
2. Lysosomal degradation of cholecystokinin-(29-33)-amide in mouse brain is dependent on tripeptidyl peptidase-I: implications for the degradation and storage of peptides in classical late-infantile neuronal ceroid lipofuscinosis.
Bernardini F; Warburton MJ
Biochem J; 2002 Sep; 366(Pt 2):521-9. PubMed ID: 12038963
[TBL] [Abstract][Full Text] [Related]
3. Tripeptidyl-peptidase I is apparently the CLN2 protein absent in classical late-infantile neuronal ceroid lipofuscinosis.
Rawlings ND; Barrett AJ
Biochim Biophys Acta; 1999 Jan; 1429(2):496-500. PubMed ID: 9989235
[TBL] [Abstract][Full Text] [Related]
4. Characterization of endopeptidase activity of tripeptidyl peptidase-I/CLN2 protein which is deficient in classical late infantile neuronal ceroid lipofuscinosis.
Ezaki J; Takeda-Ezaki M; Oda K; Kominami E
Biochem Biophys Res Commun; 2000 Feb; 268(3):904-8. PubMed ID: 10679303
[TBL] [Abstract][Full Text] [Related]
5. Tripeptidyl-peptidase I in neuronal ceroid lipofuscinoses and other lysosomal storage disorders.
Wisniewski KE; Kida E; Walus M; Wujek P; Kaczmarski W; Golabek AA
Eur J Paediatr Neurol; 2001; 5 Suppl A():73-9. PubMed ID: 11589013
[TBL] [Abstract][Full Text] [Related]
6. The lysosomal degradation of neuromedin B is dependent on tripeptidyl peptidase-I: evidence for the impairment of neuropeptide degradation in late-infantile neuronal ceroid lipofuscinosis.
Kopan S; Sivasubramaniam U; Warburton MJ
Biochem Biophys Res Commun; 2004 Jun; 319(1):58-65. PubMed ID: 15158442
[TBL] [Abstract][Full Text] [Related]
7. The specificity of lysosomal tripeptidyl peptidase-I determined by its action on angiotensin-II analogues.
Warburton MJ; Bernardini F
FEBS Lett; 2001 Jul; 500(3):145-8. PubMed ID: 11445074
[TBL] [Abstract][Full Text] [Related]
8. [Tripeptidyl-peptidase I--distribution, biogenesis, and mechanisms of activation].
Gołabek AA
Postepy Biochem; 2006; 52(1):16-23. PubMed ID: 16869297
[TBL] [Abstract][Full Text] [Related]
9. Tripeptidyl peptidase I, the late infantile neuronal ceroid lipofuscinosis gene product, initiates the lysosomal degradation of subunit c of ATP synthase.
Ezaki J; Takeda-Ezaki M; Kominami E
J Biochem; 2000 Sep; 128(3):509-16. PubMed ID: 10965052
[TBL] [Abstract][Full Text] [Related]
10. Classical late infantile neuronal ceroid lipofuscinosis fibroblasts are deficient in lysosomal tripeptidyl peptidase I.
Vines DJ; Warburton MJ
FEBS Lett; 1999 Jan; 443(2):131-5. PubMed ID: 9989590
[TBL] [Abstract][Full Text] [Related]
11. Determination of the substrate specificity of tripeptidyl-peptidase I using combinatorial peptide libraries and development of improved fluorogenic substrates.
Tian Y; Sohar I; Taylor JW; Lobel P
J Biol Chem; 2006 Mar; 281(10):6559-72. PubMed ID: 16339154
[TBL] [Abstract][Full Text] [Related]
12. Pre- and postnatal diagnosis of patients with CLN1 and CLN2 by assay of palmitoyl-protein thioesterase and tripeptidyl-peptidase I activities.
Young EP; Worthington VC; Jackson M; Winchester BG
Eur J Paediatr Neurol; 2001; 5 Suppl A():193-6. PubMed ID: 11588996
[TBL] [Abstract][Full Text] [Related]
13. Specific substrate for CLN2 protease/tripeptidyl-peptidase I assay.
Junaid MA; Brooks SS; Pullarkat RK
Eur J Paediatr Neurol; 2001; 5 Suppl A():63-8. PubMed ID: 11589010
[TBL] [Abstract][Full Text] [Related]
14. Tripeptidyl peptidases: enzymes that count.
Tomkinson B
Trends Biochem Sci; 1999 Sep; 24(9):355-9. PubMed ID: 10470035
[TBL] [Abstract][Full Text] [Related]
15. Mutations in classical late infantile neuronal ceroid lipofuscinosis disrupt transport of tripeptidyl-peptidase I to lysosomes.
Steinfeld R; Steinke HB; Isbrandt D; Kohlschütter A; Gärtner J
Hum Mol Genet; 2004 Oct; 13(20):2483-91. PubMed ID: 15317752
[TBL] [Abstract][Full Text] [Related]
16. Prosegment of tripeptidyl peptidase I is a potent, slow-binding inhibitor of its cognate enzyme.
Golabek AA; Dolzhanskaya N; Walus M; Wisniewski KE; Kida E
J Biol Chem; 2008 Jun; 283(24):16497-504. PubMed ID: 18411270
[TBL] [Abstract][Full Text] [Related]
17. Structure of tripeptidyl-peptidase I provides insight into the molecular basis of late infantile neuronal ceroid lipofuscinosis.
Pal A; Kraetzner R; Gruene T; Grapp M; Schreiber K; Grønborg M; Urlaub H; Becker S; Asif AR; Gärtner J; Sheldrick GM; Steinfeld R
J Biol Chem; 2009 Feb; 284(6):3976-84. PubMed ID: 19038966
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure and autoactivation pathway of the precursor form of human tripeptidyl-peptidase 1, the enzyme deficient in late infantile ceroid lipofuscinosis.
Guhaniyogi J; Sohar I; Das K; Stock AM; Lobel P
J Biol Chem; 2009 Feb; 284(6):3985-97. PubMed ID: 19038967
[TBL] [Abstract][Full Text] [Related]
19. Tripeptidyl-peptidase I deficiency in classical late-infantile neuronal ceroid lipofuscinosis brain tissue. Evidence for defective peptidase rather than proteinase activity.
Warburton MJ; Bernardini F
J Inherit Metab Dis; 2000 Mar; 23(2):145-54. PubMed ID: 10801056
[TBL] [Abstract][Full Text] [Related]
20. Biosynthesis, glycosylation, and enzymatic processing in vivo of human tripeptidyl-peptidase I.
Golabek AA; Kida E; Walus M; Wujek P; Mehta P; Wisniewski KE
J Biol Chem; 2003 Feb; 278(9):7135-45. PubMed ID: 12488460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]